NEUROMUSCULAR DISORDERS
ISSN:0960-8966

NEUROMUSCULAR DISORDERS

NEUROMUSCULAR DISORD
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:偏慢,4-8周
新锐分区:医学3区
年发文量:86
影响因子:2.8
JCR分区:Q2

基本信息

这本国际性的多学科期刊涵盖了儿童和成人生活中神经肌肉疾病的各个方面(包括肌营养不良、脊髓性肌萎缩、遗传性神经病、先天性肌病、肌无力、肌强直综合征、代谢性肌病和炎性肌病)。编辑们欢迎来自该领域各个领域的原创文章:·临床方面,如新的临床实体、感兴趣的病例研究、治疗、管理和康复(包括生物力学、矫形设计和手术)。·与临床综合征相关的基础科学研究,包括分子生物学和遗传学领域的进展。·与人类疾病相关的动物模型研究。该杂志面向广泛的临床医生、病理学家、相关的辅助医疗专业人员以及对神经肌肉疾病研究感兴趣的临床和基础科学家。
0960-8966SCIE/Scopus收录
2.8
3.2
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
CLINICAL NEUROLOGY 临床神经病学
3区
NEUROSCIENCES 神经科学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:CLINICAL NEUROLOGY
SCIE
Q2
121/286
学科:NEUROSCIENCES
SCIE
Q3
162/314
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:CLINICAL NEUROLOGY
SCIE
Q3
162/286
学科:NEUROSCIENCES
SCIE
Q3
198/314
89
86
2%较易偏慢,4-8周-医学-临床神经学
3.6%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
95.35%24.93%-
CiteScore:4.70
SJR:0.885
SNIP:1.004
学科类别分区排名百分位
大类:Medicine
小类:Pediatrics, Perinatology and Child Health
Q1
65 / 342
大类:Medicine
小类:Neurology (clinical)
Q2
157 / 400
大类:Medicine
小类:Neurology
Q2
84 / 194
大类:Medicine
小类:Genetics (clinical)
Q2
46 / 100

期刊高被引文献

Newborn screening for SMA in Southern Belgium
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.02.003
Clinical spectrum of neuromuscular complications after immune checkpoint inhibition
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.11.012
MYO-MRI diagnostic protocols in genetic myopathies
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.08.011
Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.02.002
Powered standing wheelchairs promote independence, health and community involvement in adolescents with Duchenne muscular dystrophy
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.01.010
The nature of respiratory muscle weakness in patients with late-onset Pompe disease
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.011
Report of a novel ATP7A mutation causing distal motor neuropathy
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.08.008
Spinal muscular atrophy with respiratory distress type 1: A multicenter retrospective study
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.10.002
Autologous hematopoietic stem cell transplantation in a patient with refractory seropositive myasthenia gravis: A case report
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.11.008
A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.03.009
Polyradiculoneuropathy in dourine-affected horses
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.03.005
Fukuyama Congenital Muscular Dystrophy
来源期刊:Neuromuscular DisordersDOI:10.1016/J.NMD.2019.06.457
Sleep-disordered breathing and effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with myotonic dystrophy type I
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.02.006
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.01.009
Evolution of bone mineral density, bone metabolism and fragility fractures in Spinal Muscular Atrophy (SMA) types 2 and 3
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.001
P.352Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): results from the SHINE study
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.514
A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.12.008
Stopping oral steroid-sparing agents at initiation of rituximab in myasthenia gravis
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.002
Myopathies featuring non-caseating granulomas: Sarcoidosis, inclusion body myositis and an unfolding overlap
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.10.007
Dropped head syndrome as a manifestation of Charcot–Marie–Tooth disease type 4C
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.11.010
Charcot-Marie-Tooth disease type 2CC due to a frameshift mutation of the neurofilament heavy polypeptide gene in an Austrian family
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.02.007
A novel case of MSTO1 gene related congenital muscular dystrophy with progressive neurological involvement
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.03.011
Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.005
Electromyography and muscle biopsy in paediatric neuromuscular disorders – Evaluation of current practice and literature review
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.10.003
Longitudinal study of upper extremity reachable workspace in fascioscapulohumeral muscular dystrophy
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.05.006
De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.09.001
A simple and rapid immunoassay predicts dysferlinopathies in peripheral blood film
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.09.008
236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1–3 June 2018
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.01.002
Muscle fiber dysfunction contributes to weakness in inclusion body myositis
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.03.001
First familial Becker muscular dystrophy in Tanzania: Clinical and genetic features,
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.01.006
EP.88Development of clinical trial simulation tool for Duchenne muscular dystrophy through the Duchenne Regulatory Science Consortium
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.494
Exome sequencing detects compound heterozygous nonsense LAMA2 mutations in two siblings with atypical phenotype and nearly normal brain MRI
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.04.001
GNE myopathy – A cross-sectional study on spatio-temporal gait characteristics
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.11.003
Thoracic circumference: A new outcome measure in spinal muscular atrophy type 1?
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.03.003
Autosomal dominant distal myopathy with nemaline rods due to p.Glu197Asp mutation in ACTA1
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.12.001
Mental wellbeing in non-ambulant youth with neuromuscular disorders: What makes the difference?
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.08.013
Membrane recruitment of nNOSµ in microdystrophin gene transfer to enhance durability
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.08.009
Mutation spectrum of 260 dystrophinopathy patients from Turkey and important highlights for genetic counseling
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.03.012
Large in-frame 5′ deletions in DMD associated with mild Duchenne muscular dystrophy: Two case reports and a review of the literature
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.09.009
240th ENMC workshop: The involvement of skeletal muscle stem cells in the pathology of muscular dystrophies 25–27 January 2019, Hoofddorp, The Netherlands
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.07.003
P.43Targeting DUX4 expression, the root cause of FSHD: identification of a drug target and development candidate
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.072
P.44Safety and tolerability of losmapimod, a selective p38α/β MAPK inhibitor, for treatment of FSHD at its root cause
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.073
P.173Ketogenic diet ameliorates dysferlinopathy phenotype in Dysf-/-mice by promoting mitochondrial function
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.06.228
Novel compound heterozygous GFPT1 mutations in a family with limb-girdle myasthenia with tubular aggregates
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.05.008
PMP22-related disease: A novel splice site acceptor variant and intrafamilial phenotype variability
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.03.010
Targeted gene approach with biochemical assay confirms ABCD1 mutation of X-linked adrenoleukodystrophy in a 62-year-old man with gait imbalance
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2018.11.007
A novel case of inclusion body myositis and myasthenia gravis
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.09.004
Assessment of muscle involvement in patients with Duchenne muscular dystrophy via segmental multifrequency bioelectrical analysis
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.08.006
Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.08.003
Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment
来源期刊:Neuromuscular DisordersDOI:10.1016/j.nmd.2019.10.007

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学3区
CLINICAL NEUROLOGY 临床神经病学
3区
NEUROSCIENCES 神经科学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
CLINICAL NEUROLOGY 临床神经病学
4区
NEUROSCIENCES 神经科学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
CLINICAL NEUROLOGY 临床神经病学
4区
NEUROSCIENCES 神经科学
4区